Triple-negative breast cancer (TNBC), which negatively expresses estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2), is a distinctive subcategory of breast cancer [7]. Here, ERBB2 is linked to triple-negative breast carcinoma.